We are also increasingly hearing about new Omicron sub-variants with names such as BA.2, BA.4 and now BA.5. The concern is these sub-variants may lead to people becoming reinfected, leading to another rise in cases.
Read More
We are also increasingly hearing about new Omicron sub-variants with names such as BA.2, BA.4 and now BA.5. The concern is these sub-variants may lead to people becoming reinfected, leading to another rise in cases.
Read More
University of Melbourne Associate Professor Torsten Seemann has won the World Health Organization (WHO) Western Pacific Innovation Challenge for his work leading the development of AusTrakka, Australia’s national pathogen genomics surveillance platform.
Read More
Published in Nature Communications, researchers behind AusTrakka outline how the platform has facilitated rapid data sharing, democratised access to computational and bioinformatic resources and expertise, and achieved national real-time genomic surveillance.
Read More
The latest COVID-19 variant, Omicron, has sparked international travel bans, stricter quarantine and a lot of “hype” worldwide – but we still have a lot to learn about the mutation
Read More
The Pathogen Genomics in Public HeAlth Surveillance Evaluation (PG-PHASE) Framework published in Genome Medicine, uses an adaptable, whole-of-system approach towards understanding the utility of pathogen genomics and whole-genome sequencing (WGS) in disease control and measuring the impact on public health processes and outcomes.
Read More
The Communicable Diseases Genomic Network (CDGN) co-chair Professor Ben Howden, featured on ABC Radio National’s Sunday Extra with Julian Morrow to discuss the important role genomic sequencing has played in the COVID-19 pandemic response.
Read More
It’s been widely publicised that the variant of SARS-CoV-2 associated with Melbourne’s outbreak is the B.1.617 variant. What do we know about it? Is it more transmissible?
Read More
Genome sequencing has been around for decades and has become faster and cheaper in more recent years. But how is it currently being used across the world in the fight against the COVID-19 pandemic?
Read More
Dr Clare Sloggett, Doherty Institute, recently presented a webinar on AusTrakka, hosted by Australian BioCommons.
Read More
The CDGN is supporting the development of proficiency testing programs (PTPs) for SARS-CoV-2 and bacteria, providing advice, bioinformatics expertise and support to the Quality Assurance Program (QAP).
Read MoreAn update on the current status of AusTrakka for SARS-CoV-2. Within weeks of its deployment, AusTrakka identified its first inter-jurisdictional transmission of SARS-CoV-2 based on genomic analysis of sequence data uploaded onto the platform.
Read More